Y-27632
Chemical compound
Y-27632 is a selective inhibitor of Rho-associated protein kinase (ROCK), which is a downstream effector of the small GTPase RhoA. This compound is widely used in scientific research to study the role of ROCK in various cellular processes, including cell migration, proliferation, and apoptosis.
Chemical Properties[edit | edit source]
Y-27632 is a pyridine derivative with the chemical formula C14H21N3O. It is a water-soluble compound that can be easily administered in biological experiments. The molecular structure of Y-27632 allows it to interact specifically with the ATP-binding site of ROCK, thereby inhibiting its kinase activity.
Mechanism of Action[edit | edit source]
Y-27632 functions by inhibiting the activity of ROCK, which is involved in the regulation of the actin cytoskeleton. ROCK phosphorylates various downstream targets, leading to changes in cell shape, motility, and contraction. By inhibiting ROCK, Y-27632 can prevent these cellular changes, making it a valuable tool for studying the role of the Rho/ROCK pathway in various physiological and pathological processes.
Applications in Research[edit | edit source]
Y-27632 is extensively used in cell culture to enhance the survival and proliferation of stem cells, particularly human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs). It has been shown to improve the efficiency of cell reprogramming and to maintain the pluripotency of stem cells in culture.
In addition to stem cell research, Y-27632 is used to study the mechanisms of cancer cell invasion and metastasis. By inhibiting ROCK, researchers can investigate the role of the Rho/ROCK pathway in tumor progression and identify potential therapeutic targets for cancer treatment.
Therapeutic Potential[edit | edit source]
Although primarily used as a research tool, Y-27632 has potential therapeutic applications. Its ability to modulate the actin cytoskeleton and cell motility suggests that it could be used to treat diseases characterized by excessive cell migration, such as fibrosis and cancer. However, further research is needed to evaluate its safety and efficacy in clinical settings.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
